In terms of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, as amended from time to time, Mangalam Drugs & Organics has informed that it attached the Compliance Certificate as received from ‘Link Intime India’ Registrar and Share Transfer Agent of the Company for the quarter ended June 30, 2023.
The above information is a part of company’s filings submitted to BSE.